BioVaxys Vaccine Platform Stimulates Robust T-cell Response Ag...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
VANCOUVER, B.C., Dec. 21, 2020 /PRNewswire-AsiaNet/ -- - BVX-0320 ACTIVATES IMMUNE SYSTEM MEMORY 'HELPER ' CD4+ AND KILLER CD8+ T-CELLS AGAINST SARS-COV-2- POTENTIAL FOR LONGER-TERM VIRAL PROTECTIONBioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTC:LMNGF) ("BioVaxys") announced today that furt...
Authors: LATEST ASIANET NEWS RELEASES
